nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—RXRA—thyroid cancer	0.714	1	CbGaD
Isotretinoin—RXRG—neck—thyroid cancer	0.00347	0.157	CbGeAlD
Isotretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—THRB—thyroid cancer	0.0032	0.028	CbGpPWpGaD
Isotretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—THRB—thyroid cancer	0.00293	0.0256	CbGpPWpGaD
Isotretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—THRB—thyroid cancer	0.00287	0.0251	CbGpPWpGaD
Isotretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—THRB—thyroid cancer	0.00276	0.0241	CbGpPWpGaD
Isotretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—THRB—thyroid cancer	0.00276	0.0241	CbGpPWpGaD
Isotretinoin—RXRG—Regulation of Androgen receptor activity—TRIM24—thyroid cancer	0.00257	0.0225	CbGpPWpGaD
Isotretinoin—RXRB—Vitamin D Metabolism—RXRA—thyroid cancer	0.00251	0.022	CbGpPWpGaD
Isotretinoin—RXRB—Regulation of Androgen receptor activity—TRIM24—thyroid cancer	0.00242	0.0211	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptors—THRB—thyroid cancer	0.00237	0.0207	CbGpPWpGaD
Isotretinoin—Acitretin—RXRA—thyroid cancer	0.00228	0.38	CrCbGaD
Isotretinoin—Alitretinoin—RXRA—thyroid cancer	0.00218	0.364	CrCbGaD
Isotretinoin—RXRG—Nuclear Receptors—THRB—thyroid cancer	0.00216	0.0189	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptors—THRB—thyroid cancer	0.00212	0.0185	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptors—THRB—thyroid cancer	0.00203	0.0178	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors—THRB—thyroid cancer	0.00203	0.0178	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00187	0.0163	CbGpPWpGaD
Isotretinoin—RXRG—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00171	0.0149	CbGpPWpGaD
Isotretinoin—RARB—thyroid gland—thyroid cancer	0.00169	0.0763	CbGeAlD
Isotretinoin—RARB—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00168	0.0146	CbGpPWpGaD
Isotretinoin—RXRA—head—thyroid cancer	0.00167	0.0754	CbGeAlD
Isotretinoin—RXRG—thyroid gland—thyroid cancer	0.00165	0.0746	CbGeAlD
Isotretinoin—RXRB—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00161	0.014	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00161	0.014	CbGpPWpGaD
Isotretinoin—RXRB—thyroid gland—thyroid cancer	0.00155	0.0702	CbGeAlD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—LAMA2—thyroid cancer	0.00154	0.0135	CbGpPWpGaD
Isotretinoin—Tretinoin—RXRA—thyroid cancer	0.00154	0.256	CrCbGaD
Isotretinoin—RARB—head—thyroid cancer	0.0015	0.0677	CbGeAlD
Isotretinoin—RXRG—head—thyroid cancer	0.00147	0.0662	CbGeAlD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—LAMA2—thyroid cancer	0.00145	0.0126	CbGpPWpGaD
Isotretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—THRB—thyroid cancer	0.00144	0.0125	CbGpPWpGaD
Isotretinoin—RARG—thyroid gland—thyroid cancer	0.00138	0.0623	CbGeAlD
Isotretinoin—RXRB—head—thyroid cancer	0.00138	0.0622	CbGeAlD
Isotretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—RXRA—thyroid cancer	0.00136	0.0119	CbGpPWpGaD
Isotretinoin—RARG—Retinoic acid receptors-mediated signaling—CDK1—thyroid cancer	0.00131	0.0114	CbGpPWpGaD
Isotretinoin—RARA—thyroid gland—thyroid cancer	0.0013	0.0586	CbGeAlD
Isotretinoin—RXRA—Regulation of Androgen receptor activity—TRIM24—thyroid cancer	0.00126	0.011	CbGpPWpGaD
Isotretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—RXRA—thyroid cancer	0.00125	0.0109	CbGpPWpGaD
Isotretinoin—RARG—head—thyroid cancer	0.00122	0.0552	CbGeAlD
Isotretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—RXRA—thyroid cancer	0.00122	0.0107	CbGpPWpGaD
Isotretinoin—RARG—Retinoic acid receptors-mediated signaling—RXRA—thyroid cancer	0.00121	0.0106	CbGpPWpGaD
Isotretinoin—RXRG—Retinoic acid receptors-mediated signaling—CDK1—thyroid cancer	0.0012	0.0104	CbGpPWpGaD
Isotretinoin—RARB—Retinoic acid receptors-mediated signaling—CDK1—thyroid cancer	0.00117	0.0102	CbGpPWpGaD
Isotretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—RXRA—thyroid cancer	0.00117	0.0102	CbGpPWpGaD
Isotretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—RXRA—thyroid cancer	0.00117	0.0102	CbGpPWpGaD
Isotretinoin—RARA—head—thyroid cancer	0.00115	0.0519	CbGeAlD
Isotretinoin—RARA—Retinoic acid receptors-mediated signaling—CDK1—thyroid cancer	0.00112	0.00982	CbGpPWpGaD
Isotretinoin—RXRB—Retinoic acid receptors-mediated signaling—CDK1—thyroid cancer	0.00112	0.00982	CbGpPWpGaD
Isotretinoin—RXRG—Retinoic acid receptors-mediated signaling—RXRA—thyroid cancer	0.00111	0.0097	CbGpPWpGaD
Isotretinoin—RARB—Retinoic acid receptors-mediated signaling—RXRA—thyroid cancer	0.00109	0.00951	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptors—THRB—thyroid cancer	0.00106	0.00926	CbGpPWpGaD
Isotretinoin—RARB—lymph node—thyroid cancer	0.00105	0.0474	CbGeAlD
Isotretinoin—RARA—Retinoic acid receptors-mediated signaling—RXRA—thyroid cancer	0.00104	0.00912	CbGpPWpGaD
Isotretinoin—RXRB—Retinoic acid receptors-mediated signaling—RXRA—thyroid cancer	0.00104	0.00912	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptors—RXRA—thyroid cancer	0.001	0.00877	CbGpPWpGaD
Isotretinoin—RXRG—Nuclear Receptors—RXRA—thyroid cancer	0.000919	0.00803	CbGpPWpGaD
Isotretinoin—RARG—Vitamin A and Carotenoid Metabolism—RXRA—thyroid cancer	0.00091	0.00795	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptors—RXRA—thyroid cancer	0.000901	0.00787	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptors—RXRA—thyroid cancer	0.000864	0.00755	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors—RXRA—thyroid cancer	0.000864	0.00755	CbGpPWpGaD
Isotretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—PPARG—thyroid cancer	0.00086	0.00751	CbGpPWpGaD
Isotretinoin—RARG—lymph node—thyroid cancer	0.000857	0.0387	CbGeAlD
Isotretinoin—RXRA—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.000838	0.00731	CbGpPWpGaD
Isotretinoin—RXRG—Vitamin A and Carotenoid Metabolism—RXRA—thyroid cancer	0.000833	0.00727	CbGpPWpGaD
Isotretinoin—RARB—Vitamin A and Carotenoid Metabolism—RXRA—thyroid cancer	0.000816	0.00713	CbGpPWpGaD
Isotretinoin—RARA—lymph node—thyroid cancer	0.000806	0.0364	CbGeAlD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—RXRA—thyroid cancer	0.000803	0.00701	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.000794	0.00693	CbGpPWpGaD
Isotretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—PPARG—thyroid cancer	0.000786	0.00686	CbGpPWpGaD
Isotretinoin—RARA—Vitamin A and Carotenoid Metabolism—RXRA—thyroid cancer	0.000783	0.00684	CbGpPWpGaD
Isotretinoin—RXRB—Vitamin A and Carotenoid Metabolism—RXRA—thyroid cancer	0.000783	0.00684	CbGpPWpGaD
Isotretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—thyroid cancer	0.000771	0.00673	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—RXRA—thyroid cancer	0.000755	0.00659	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—LAMA2—thyroid cancer	0.000755	0.00659	CbGpPWpGaD
Isotretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—thyroid cancer	0.000739	0.00645	CbGpPWpGaD
Isotretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—thyroid cancer	0.000739	0.00645	CbGpPWpGaD
Isotretinoin—RXRG—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.000726	0.00634	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.000712	0.00622	CbGpPWpGaD
Isotretinoin—RXRG—Regulation of Androgen receptor activity—RXRA—thyroid cancer	0.000704	0.00615	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000694	0.00606	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.000683	0.00596	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.000683	0.00596	CbGpPWpGaD
Isotretinoin—RXRB—Regulation of Androgen receptor activity—RXRA—thyroid cancer	0.000662	0.00578	CbGpPWpGaD
Isotretinoin—RXRA—PPAR Alpha Pathway—CDK1—thyroid cancer	0.000657	0.00574	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptors—PPARG—thyroid cancer	0.000634	0.00554	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000622	0.00543	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000596	0.00521	CbGpPWpGaD
Isotretinoin—RXRA—Retinoic acid receptors-mediated signaling—CDK1—thyroid cancer	0.000586	0.00512	CbGpPWpGaD
Isotretinoin—RXRG—Nuclear Receptors—PPARG—thyroid cancer	0.00058	0.00507	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptors—PPARG—thyroid cancer	0.000569	0.00497	CbGpPWpGaD
Isotretinoin—RXRA—The citric acid (TCA) cycle and respiratory electron transport—NDUFA13—thyroid cancer	0.000557	0.00487	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptors—PPARG—thyroid cancer	0.000546	0.00476	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptors—PPARG—thyroid cancer	0.000546	0.00476	CbGpPWpGaD
Isotretinoin—RARG—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000501	0.00438	CbGpPWpGaD
Isotretinoin—RXRG—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000459	0.004	CbGpPWpGaD
Isotretinoin—RARB—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00045	0.00393	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000447	0.0039	CbGpPWpGaD
Isotretinoin—RXRA—Transcription factor regulation in adipogenesis—PPARG—thyroid cancer	0.00044	0.00384	CbGpPWpGaD
Isotretinoin—RARA—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000431	0.00376	CbGpPWpGaD
Isotretinoin—RXRB—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000431	0.00376	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000408	0.00357	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000401	0.0035	CbGpPWpGaD
Isotretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—thyroid cancer	0.000385	0.00336	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000384	0.00335	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000384	0.00335	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—RXRA—thyroid cancer	0.000344	0.003	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—RXRA—thyroid cancer	0.000323	0.00282	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—THRB—thyroid cancer	0.000323	0.00282	CbGpPWpGaD
Isotretinoin—RARG—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.000303	0.00265	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—THRB—thyroid cancer	0.000295	0.00258	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—THRB—thyroid cancer	0.00029	0.00253	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptors—PPARG—thyroid cancer	0.000284	0.00248	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—THRB—thyroid cancer	0.000278	0.00242	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—THRB—thyroid cancer	0.000278	0.00242	CbGpPWpGaD
Isotretinoin—RXRG—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.000277	0.00242	CbGpPWpGaD
Isotretinoin—RXRA—PPAR Alpha Pathway—CCND1—thyroid cancer	0.000274	0.00239	CbGpPWpGaD
Isotretinoin—RARB—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.000272	0.00237	CbGpPWpGaD
Isotretinoin—RARA—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.000261	0.00228	CbGpPWpGaD
Isotretinoin—RXRB—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.000261	0.00228	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—HIF1A—thyroid cancer	0.000255	0.00223	CbGpPWpGaD
Isotretinoin—RXRA—Circadian Clock—HIF1A—thyroid cancer	0.000249	0.00217	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000248	0.00216	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—HIF1A—thyroid cancer	0.00024	0.00209	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000237	0.00207	CbGpPWpGaD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—HRAS—thyroid cancer	0.000227	0.00198	CbGpPWpGaD
Isotretinoin—RXRA—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000225	0.00196	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—PPARG—thyroid cancer	0.000217	0.00189	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—TRIM33—thyroid cancer	0.000215	0.00188	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—thyroid cancer	0.000213	0.00186	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—MEN1—thyroid cancer	0.000205	0.00179	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—PPARG—thyroid cancer	0.000204	0.00178	CbGpPWpGaD
Isotretinoin—RXRG—a6b1 and a6b4 Integrin signaling—AKT1—thyroid cancer	0.0002	0.00175	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—TRIM33—thyroid cancer	0.0002	0.00175	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—TRIM33—thyroid cancer	0.000197	0.00172	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—TRIM33—thyroid cancer	0.000193	0.00168	CbGpPWpGaD
Isotretinoin—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—thyroid cancer	0.000188	0.00165	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—MEN1—thyroid cancer	0.000188	0.00164	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—TRIM33—thyroid cancer	0.000185	0.00161	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—TRIM33—thyroid cancer	0.000185	0.00161	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—MEN1—thyroid cancer	0.000184	0.00161	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—SLC5A5—thyroid cancer	0.000183	0.00159	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—MEN1—thyroid cancer	0.000176	0.00154	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—MEN1—thyroid cancer	0.000176	0.00154	CbGpPWpGaD
Isotretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—thyroid cancer	0.000162	0.00141	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—THRB—thyroid cancer	0.000155	0.00136	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—THRB—thyroid cancer	0.000145	0.00126	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000143	0.00125	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—THRB—thyroid cancer	0.000142	0.00124	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—THRB—thyroid cancer	0.000139	0.00122	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—RXRA—thyroid cancer	0.000137	0.0012	CbGpPWpGaD
Isotretinoin—RXRA—Retinoic acid receptors-mediated signaling—AKT1—thyroid cancer	0.000136	0.00119	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—THRB—thyroid cancer	0.000134	0.00117	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—THRB—thyroid cancer	0.000134	0.00117	CbGpPWpGaD
Isotretinoin—RXRA—NRF2 pathway—NRG1—thyroid cancer	0.000133	0.00116	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—RXRA—thyroid cancer	0.000125	0.0011	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—HIF1A—thyroid cancer	0.000125	0.00109	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—RXRA—thyroid cancer	0.000123	0.00107	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000123	0.00107	CbGpPWpGaD
Isotretinoin—RXRA—PPARA activates gene expression—PPARG—thyroid cancer	0.000121	0.00106	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—thyroid cancer	0.000119	0.00104	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—RXRA—thyroid cancer	0.000118	0.00103	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—RXRA—thyroid cancer	0.000118	0.00103	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000118	0.00103	CbGpPWpGaD
Isotretinoin—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000112	0.000782	CcSEcCtD
Isotretinoin—Hypersensitivity—Sorafenib—thyroid cancer	0.000112	0.000782	CcSEcCtD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—thyroid cancer	0.000111	0.000971	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000111	0.000971	CbGpPWpGaD
Isotretinoin—Renal impairment—Doxorubicin—thyroid cancer	0.000111	0.000775	CcSEcCtD
Isotretinoin—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00011	0.000772	CcSEcCtD
Isotretinoin—Face oedema—Epirubicin—thyroid cancer	0.00011	0.00077	CcSEcCtD
Isotretinoin—Asthenia—Sorafenib—thyroid cancer	0.000109	0.000761	CcSEcCtD
Isotretinoin—Cardiac arrest—Epirubicin—thyroid cancer	0.000108	0.000758	CcSEcCtD
Isotretinoin—Cardiac failure—Doxorubicin—thyroid cancer	0.000108	0.000756	CcSEcCtD
Isotretinoin—Mood swings—Epirubicin—thyroid cancer	0.000108	0.000756	CcSEcCtD
Isotretinoin—Lethargy—Doxorubicin—thyroid cancer	0.000108	0.000753	CcSEcCtD
Isotretinoin—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000108	0.000753	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000107	0.000937	CbGpPWpGaD
Isotretinoin—Pruritus—Sorafenib—thyroid cancer	0.000107	0.00075	CcSEcCtD
Isotretinoin—Blood creatinine increased—Epirubicin—thyroid cancer	0.000107	0.000747	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000107	0.000931	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—PPARG—thyroid cancer	0.000106	0.000928	CbGpPWpGaD
Isotretinoin—Dehydration—Epirubicin—thyroid cancer	0.000106	0.000742	CcSEcCtD
Isotretinoin—Pain in extremity—Doxorubicin—thyroid cancer	0.000105	0.000738	CcSEcCtD
Isotretinoin—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000105	0.000738	CcSEcCtD
Isotretinoin—Osteoarthritis—Doxorubicin—thyroid cancer	0.000105	0.000738	CcSEcCtD
Isotretinoin—RARG—Gene Expression—TPR—thyroid cancer	0.000105	0.000917	CbGpPWpGaD
Isotretinoin—Dry skin—Epirubicin—thyroid cancer	0.000104	0.000731	CcSEcCtD
Isotretinoin—Affect lability—Doxorubicin—thyroid cancer	0.000104	0.000726	CcSEcCtD
Isotretinoin—Diarrhoea—Sorafenib—thyroid cancer	0.000104	0.000726	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000103	0.000898	CbGpPWpGaD
Isotretinoin—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000103	0.000718	CcSEcCtD
Isotretinoin—Nasopharyngitis—Epirubicin—thyroid cancer	0.000102	0.000713	CcSEcCtD
Isotretinoin—Face oedema—Doxorubicin—thyroid cancer	0.000102	0.000712	CcSEcCtD
Isotretinoin—Gastritis—Epirubicin—thyroid cancer	0.000101	0.000706	CcSEcCtD
Isotretinoin—Cardiac arrest—Doxorubicin—thyroid cancer	0.0001	0.000702	CcSEcCtD
Isotretinoin—Dizziness—Sorafenib—thyroid cancer	0.0001	0.000701	CcSEcCtD
Isotretinoin—Mood swings—Doxorubicin—thyroid cancer	9.99e-05	0.000699	CcSEcCtD
Isotretinoin—Abdominal distension—Epirubicin—thyroid cancer	9.91e-05	0.000694	CcSEcCtD
Isotretinoin—RXRA—Metabolism—MINPP1—thyroid cancer	9.89e-05	0.000863	CbGpPWpGaD
Isotretinoin—Blood creatinine increased—Doxorubicin—thyroid cancer	9.87e-05	0.000691	CcSEcCtD
Isotretinoin—RARG—Gene Expression—MEN1—thyroid cancer	9.87e-05	0.000862	CbGpPWpGaD
Isotretinoin—Asthma—Epirubicin—thyroid cancer	9.85e-05	0.000689	CcSEcCtD
Isotretinoin—Dysphagia—Epirubicin—thyroid cancer	9.85e-05	0.000689	CcSEcCtD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—thyroid cancer	9.82e-05	0.000857	CbGpPWpGaD
Isotretinoin—Dehydration—Doxorubicin—thyroid cancer	9.8e-05	0.000686	CcSEcCtD
Isotretinoin—Dry skin—Doxorubicin—thyroid cancer	9.66e-05	0.000676	CcSEcCtD
Isotretinoin—Pancreatitis—Epirubicin—thyroid cancer	9.65e-05	0.000676	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—TRIM33—thyroid cancer	9.64e-05	0.000841	CbGpPWpGaD
Isotretinoin—Vomiting—Sorafenib—thyroid cancer	9.63e-05	0.000674	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—TPR—thyroid cancer	9.6e-05	0.000839	CbGpPWpGaD
Isotretinoin—Rash—Sorafenib—thyroid cancer	9.55e-05	0.000669	CcSEcCtD
Isotretinoin—Dermatitis—Sorafenib—thyroid cancer	9.54e-05	0.000668	CcSEcCtD
Isotretinoin—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	9.49e-05	0.000665	CcSEcCtD
Isotretinoin—Headache—Sorafenib—thyroid cancer	9.49e-05	0.000665	CcSEcCtD
Isotretinoin—Nasopharyngitis—Doxorubicin—thyroid cancer	9.43e-05	0.00066	CcSEcCtD
Isotretinoin—RARB—Gene Expression—TPR—thyroid cancer	9.42e-05	0.000822	CbGpPWpGaD
Isotretinoin—Gastritis—Doxorubicin—thyroid cancer	9.33e-05	0.000653	CcSEcCtD
Isotretinoin—Dysuria—Epirubicin—thyroid cancer	9.21e-05	0.000645	CcSEcCtD
Isotretinoin—Neutropenia—Epirubicin—thyroid cancer	9.21e-05	0.000645	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—MEN1—thyroid cancer	9.19e-05	0.000802	CbGpPWpGaD
Isotretinoin—Abdominal distension—Doxorubicin—thyroid cancer	9.17e-05	0.000642	CcSEcCtD
Isotretinoin—Upper respiratory tract infection—Epirubicin—thyroid cancer	9.15e-05	0.000641	CcSEcCtD
Isotretinoin—Dysphagia—Doxorubicin—thyroid cancer	9.11e-05	0.000638	CcSEcCtD
Isotretinoin—Asthma—Doxorubicin—thyroid cancer	9.11e-05	0.000638	CcSEcCtD
Isotretinoin—Pollakiuria—Epirubicin—thyroid cancer	9.1e-05	0.000637	CcSEcCtD
Isotretinoin—RARA—Gene Expression—TPR—thyroid cancer	9.03e-05	0.000788	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—TPR—thyroid cancer	9.03e-05	0.000788	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—MEN1—thyroid cancer	9.03e-05	0.000788	CbGpPWpGaD
Isotretinoin—Nausea—Sorafenib—thyroid cancer	9e-05	0.00063	CcSEcCtD
Isotretinoin—Photosensitivity reaction—Epirubicin—thyroid cancer	8.99e-05	0.000629	CcSEcCtD
Isotretinoin—Weight increased—Epirubicin—thyroid cancer	8.96e-05	0.000627	CcSEcCtD
Isotretinoin—Pancreatitis—Doxorubicin—thyroid cancer	8.93e-05	0.000625	CcSEcCtD
Isotretinoin—Weight decreased—Epirubicin—thyroid cancer	8.91e-05	0.000624	CcSEcCtD
Isotretinoin—RARB—Gene Expression—MEN1—thyroid cancer	8.85e-05	0.000773	CbGpPWpGaD
Isotretinoin—Pneumonia—Epirubicin—thyroid cancer	8.83e-05	0.000618	CcSEcCtD
Isotretinoin—Drowsiness—Epirubicin—thyroid cancer	8.78e-05	0.000615	CcSEcCtD
Isotretinoin—Infestation NOS—Epirubicin—thyroid cancer	8.78e-05	0.000615	CcSEcCtD
Isotretinoin—Infestation—Epirubicin—thyroid cancer	8.78e-05	0.000615	CcSEcCtD
Isotretinoin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	8.7e-05	0.000609	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—PPARG—thyroid cancer	8.66e-05	0.000756	CbGpPWpGaD
Isotretinoin—Renal failure—Epirubicin—thyroid cancer	8.63e-05	0.000604	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Epirubicin—thyroid cancer	8.61e-05	0.000603	CcSEcCtD
Isotretinoin—Stomatitis—Epirubicin—thyroid cancer	8.56e-05	0.000599	CcSEcCtD
Isotretinoin—Conjunctivitis—Epirubicin—thyroid cancer	8.53e-05	0.000597	CcSEcCtD
Isotretinoin—Urinary tract infection—Epirubicin—thyroid cancer	8.53e-05	0.000597	CcSEcCtD
Isotretinoin—Dysuria—Doxorubicin—thyroid cancer	8.52e-05	0.000596	CcSEcCtD
Isotretinoin—Neutropenia—Doxorubicin—thyroid cancer	8.52e-05	0.000596	CcSEcCtD
Isotretinoin—RXRB—Gene Expression—MEN1—thyroid cancer	8.49e-05	0.000741	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—MEN1—thyroid cancer	8.49e-05	0.000741	CbGpPWpGaD
Isotretinoin—Upper respiratory tract infection—Doxorubicin—thyroid cancer	8.47e-05	0.000593	CcSEcCtD
Isotretinoin—Sweating—Epirubicin—thyroid cancer	8.42e-05	0.000589	CcSEcCtD
Isotretinoin—Pollakiuria—Doxorubicin—thyroid cancer	8.42e-05	0.000589	CcSEcCtD
Isotretinoin—RXRA—Metabolism—NDUFA13—thyroid cancer	8.41e-05	0.000734	CbGpPWpGaD
Isotretinoin—Haematuria—Epirubicin—thyroid cancer	8.37e-05	0.000586	CcSEcCtD
Isotretinoin—Photosensitivity reaction—Doxorubicin—thyroid cancer	8.32e-05	0.000582	CcSEcCtD
Isotretinoin—Weight increased—Doxorubicin—thyroid cancer	8.29e-05	0.000581	CcSEcCtD
Isotretinoin—Epistaxis—Epirubicin—thyroid cancer	8.28e-05	0.00058	CcSEcCtD
Isotretinoin—Weight decreased—Doxorubicin—thyroid cancer	8.24e-05	0.000577	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	8.24e-05	0.000719	CbGpPWpGaD
Isotretinoin—Sinusitis—Epirubicin—thyroid cancer	8.24e-05	0.000577	CcSEcCtD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	8.19e-05	0.000715	CbGpPWpGaD
Isotretinoin—Agranulocytosis—Epirubicin—thyroid cancer	8.19e-05	0.000574	CcSEcCtD
Isotretinoin—Pneumonia—Doxorubicin—thyroid cancer	8.17e-05	0.000572	CcSEcCtD
Isotretinoin—Drowsiness—Doxorubicin—thyroid cancer	8.12e-05	0.000569	CcSEcCtD
Isotretinoin—Infestation NOS—Doxorubicin—thyroid cancer	8.12e-05	0.000569	CcSEcCtD
Isotretinoin—Infestation—Doxorubicin—thyroid cancer	8.12e-05	0.000569	CcSEcCtD
Isotretinoin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	8.05e-05	0.000564	CcSEcCtD
Isotretinoin—Renal failure—Doxorubicin—thyroid cancer	7.98e-05	0.000559	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Doxorubicin—thyroid cancer	7.96e-05	0.000557	CcSEcCtD
Isotretinoin—RXRG—Generic Transcription Pathway—PPARG—thyroid cancer	7.92e-05	0.000692	CbGpPWpGaD
Isotretinoin—Haemoglobin—Epirubicin—thyroid cancer	7.92e-05	0.000555	CcSEcCtD
Isotretinoin—Stomatitis—Doxorubicin—thyroid cancer	7.92e-05	0.000554	CcSEcCtD
Isotretinoin—RXRA—Metabolism—CHST14—thyroid cancer	7.9e-05	0.00069	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	7.9e-05	0.00069	CbGpPWpGaD
Isotretinoin—Conjunctivitis—Doxorubicin—thyroid cancer	7.9e-05	0.000553	CcSEcCtD
Isotretinoin—Urinary tract infection—Doxorubicin—thyroid cancer	7.9e-05	0.000553	CcSEcCtD
Isotretinoin—Haemorrhage—Epirubicin—thyroid cancer	7.88e-05	0.000552	CcSEcCtD
Isotretinoin—Hepatitis—Epirubicin—thyroid cancer	7.88e-05	0.000552	CcSEcCtD
Isotretinoin—Hypoaesthesia—Epirubicin—thyroid cancer	7.84e-05	0.000549	CcSEcCtD
Isotretinoin—Pharyngitis—Epirubicin—thyroid cancer	7.82e-05	0.000548	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—CP—thyroid cancer	7.81e-05	0.000682	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—TPR—thyroid cancer	7.81e-05	0.000682	CbGpPWpGaD
Isotretinoin—Sweating—Doxorubicin—thyroid cancer	7.79e-05	0.000545	CcSEcCtD
Isotretinoin—Urinary tract disorder—Epirubicin—thyroid cancer	7.78e-05	0.000545	CcSEcCtD
Isotretinoin—RARB—Generic Transcription Pathway—PPARG—thyroid cancer	7.77e-05	0.000678	CbGpPWpGaD
Isotretinoin—Oedema peripheral—Epirubicin—thyroid cancer	7.76e-05	0.000544	CcSEcCtD
Isotretinoin—Haematuria—Doxorubicin—thyroid cancer	7.74e-05	0.000542	CcSEcCtD
Isotretinoin—Urethral disorder—Epirubicin—thyroid cancer	7.73e-05	0.000541	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	7.69e-05	0.000671	CbGpPWpGaD
Isotretinoin—Epistaxis—Doxorubicin—thyroid cancer	7.66e-05	0.000536	CcSEcCtD
Isotretinoin—Sinusitis—Doxorubicin—thyroid cancer	7.62e-05	0.000534	CcSEcCtD
Isotretinoin—Visual impairment—Epirubicin—thyroid cancer	7.59e-05	0.000532	CcSEcCtD
Isotretinoin—Agranulocytosis—Doxorubicin—thyroid cancer	7.58e-05	0.000531	CcSEcCtD
Isotretinoin—Erythema multiforme—Epirubicin—thyroid cancer	7.45e-05	0.000522	CcSEcCtD
Isotretinoin—RARA—Generic Transcription Pathway—PPARG—thyroid cancer	7.45e-05	0.00065	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—PPARG—thyroid cancer	7.45e-05	0.00065	CbGpPWpGaD
Isotretinoin—Eye disorder—Epirubicin—thyroid cancer	7.36e-05	0.000516	CcSEcCtD
Isotretinoin—Tinnitus—Epirubicin—thyroid cancer	7.35e-05	0.000514	CcSEcCtD
Isotretinoin—Haemoglobin—Doxorubicin—thyroid cancer	7.33e-05	0.000513	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	7.32e-05	0.000639	CbGpPWpGaD
Isotretinoin—Flushing—Epirubicin—thyroid cancer	7.31e-05	0.000512	CcSEcCtD
Isotretinoin—Hepatitis—Doxorubicin—thyroid cancer	7.29e-05	0.000511	CcSEcCtD
Isotretinoin—Haemorrhage—Doxorubicin—thyroid cancer	7.29e-05	0.000511	CcSEcCtD
Isotretinoin—Hypoaesthesia—Doxorubicin—thyroid cancer	7.26e-05	0.000508	CcSEcCtD
Isotretinoin—Pharyngitis—Doxorubicin—thyroid cancer	7.24e-05	0.000507	CcSEcCtD
Isotretinoin—Urinary tract disorder—Doxorubicin—thyroid cancer	7.2e-05	0.000504	CcSEcCtD
Isotretinoin—Oedema peripheral—Doxorubicin—thyroid cancer	7.18e-05	0.000503	CcSEcCtD
Isotretinoin—Angiopathy—Epirubicin—thyroid cancer	7.15e-05	0.000501	CcSEcCtD
Isotretinoin—Urethral disorder—Doxorubicin—thyroid cancer	7.15e-05	0.0005	CcSEcCtD
Isotretinoin—Chills—Epirubicin—thyroid cancer	7.07e-05	0.000495	CcSEcCtD
Isotretinoin—Arrhythmia—Epirubicin—thyroid cancer	7.04e-05	0.000493	CcSEcCtD
Isotretinoin—Visual impairment—Doxorubicin—thyroid cancer	7.03e-05	0.000492	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	7.02e-05	0.000613	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—THRB—thyroid cancer	6.97e-05	0.000608	CbGpPWpGaD
Isotretinoin—Alopecia—Epirubicin—thyroid cancer	6.96e-05	0.000488	CcSEcCtD
Isotretinoin—Mental disorder—Epirubicin—thyroid cancer	6.9e-05	0.000483	CcSEcCtD
Isotretinoin—Erythema multiforme—Doxorubicin—thyroid cancer	6.89e-05	0.000483	CcSEcCtD
Isotretinoin—Malnutrition—Epirubicin—thyroid cancer	6.86e-05	0.00048	CcSEcCtD
Isotretinoin—Erythema—Epirubicin—thyroid cancer	6.86e-05	0.00048	CcSEcCtD
Isotretinoin—Eye disorder—Doxorubicin—thyroid cancer	6.81e-05	0.000477	CcSEcCtD
Isotretinoin—Tinnitus—Doxorubicin—thyroid cancer	6.8e-05	0.000476	CcSEcCtD
Isotretinoin—Flushing—Doxorubicin—thyroid cancer	6.77e-05	0.000474	CcSEcCtD
Isotretinoin—Flatulence—Epirubicin—thyroid cancer	6.76e-05	0.000473	CcSEcCtD
Isotretinoin—Tension—Epirubicin—thyroid cancer	6.73e-05	0.000471	CcSEcCtD
Isotretinoin—Nervousness—Epirubicin—thyroid cancer	6.66e-05	0.000467	CcSEcCtD
Isotretinoin—Back pain—Epirubicin—thyroid cancer	6.64e-05	0.000465	CcSEcCtD
Isotretinoin—Angiopathy—Doxorubicin—thyroid cancer	6.62e-05	0.000463	CcSEcCtD
Isotretinoin—RARG—Gene Expression—RXRA—thyroid cancer	6.6e-05	0.000577	CbGpPWpGaD
Isotretinoin—Chills—Doxorubicin—thyroid cancer	6.54e-05	0.000458	CcSEcCtD
Isotretinoin—Arrhythmia—Doxorubicin—thyroid cancer	6.51e-05	0.000456	CcSEcCtD
Isotretinoin—Vision blurred—Epirubicin—thyroid cancer	6.47e-05	0.000453	CcSEcCtD
Isotretinoin—Alopecia—Doxorubicin—thyroid cancer	6.44e-05	0.000451	CcSEcCtD
Isotretinoin—Mental disorder—Doxorubicin—thyroid cancer	6.39e-05	0.000447	CcSEcCtD
Isotretinoin—RXRA—Metabolism—HPGD—thyroid cancer	6.37e-05	0.000556	CbGpPWpGaD
Isotretinoin—Ill-defined disorder—Epirubicin—thyroid cancer	6.37e-05	0.000446	CcSEcCtD
Isotretinoin—Malnutrition—Doxorubicin—thyroid cancer	6.35e-05	0.000444	CcSEcCtD
Isotretinoin—Erythema—Doxorubicin—thyroid cancer	6.35e-05	0.000444	CcSEcCtD
Isotretinoin—Anaemia—Epirubicin—thyroid cancer	6.34e-05	0.000444	CcSEcCtD
Isotretinoin—Agitation—Epirubicin—thyroid cancer	6.3e-05	0.000441	CcSEcCtD
Isotretinoin—Flatulence—Doxorubicin—thyroid cancer	6.26e-05	0.000438	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—CDK1—thyroid cancer	6.23e-05	0.000544	CbGpPWpGaD
Isotretinoin—Tension—Doxorubicin—thyroid cancer	6.23e-05	0.000436	CcSEcCtD
Isotretinoin—Malaise—Epirubicin—thyroid cancer	6.19e-05	0.000433	CcSEcCtD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	6.18e-05	0.00054	CbGpPWpGaD
Isotretinoin—Nervousness—Doxorubicin—thyroid cancer	6.17e-05	0.000432	CcSEcCtD
Isotretinoin—Syncope—Epirubicin—thyroid cancer	6.15e-05	0.000431	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	6.15e-05	0.000537	CbGpPWpGaD
Isotretinoin—Back pain—Doxorubicin—thyroid cancer	6.14e-05	0.00043	CcSEcCtD
Isotretinoin—Palpitations—Epirubicin—thyroid cancer	6.06e-05	0.000424	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—RXRA—thyroid cancer	6.04e-05	0.000527	CbGpPWpGaD
Isotretinoin—Loss of consciousness—Epirubicin—thyroid cancer	6.03e-05	0.000422	CcSEcCtD
Isotretinoin—Cough—Epirubicin—thyroid cancer	5.99e-05	0.000419	CcSEcCtD
Isotretinoin—Vision blurred—Doxorubicin—thyroid cancer	5.98e-05	0.000419	CcSEcCtD
Isotretinoin—Convulsion—Epirubicin—thyroid cancer	5.94e-05	0.000416	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	5.93e-05	0.000518	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—RXRA—thyroid cancer	5.92e-05	0.000517	CbGpPWpGaD
Isotretinoin—Hypertension—Epirubicin—thyroid cancer	5.92e-05	0.000415	CcSEcCtD
Isotretinoin—Ill-defined disorder—Doxorubicin—thyroid cancer	5.89e-05	0.000412	CcSEcCtD
Isotretinoin—Anaemia—Doxorubicin—thyroid cancer	5.87e-05	0.000411	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	5.85e-05	0.000511	CbGpPWpGaD
Isotretinoin—Myalgia—Epirubicin—thyroid cancer	5.84e-05	0.000409	CcSEcCtD
Isotretinoin—Chest pain—Epirubicin—thyroid cancer	5.84e-05	0.000409	CcSEcCtD
Isotretinoin—Arthralgia—Epirubicin—thyroid cancer	5.84e-05	0.000409	CcSEcCtD
Isotretinoin—Agitation—Doxorubicin—thyroid cancer	5.83e-05	0.000408	CcSEcCtD
Isotretinoin—Anxiety—Epirubicin—thyroid cancer	5.82e-05	0.000408	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	5.8e-05	0.000406	CcSEcCtD
Isotretinoin—Discomfort—Epirubicin—thyroid cancer	5.77e-05	0.000404	CcSEcCtD
Isotretinoin—Malaise—Doxorubicin—thyroid cancer	5.72e-05	0.000401	CcSEcCtD
Isotretinoin—Dry mouth—Epirubicin—thyroid cancer	5.71e-05	0.0004	CcSEcCtD
Isotretinoin—Syncope—Doxorubicin—thyroid cancer	5.69e-05	0.000399	CcSEcCtD
Isotretinoin—RARA—Gene Expression—RXRA—thyroid cancer	5.68e-05	0.000496	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—RXRA—thyroid cancer	5.68e-05	0.000496	CbGpPWpGaD
Isotretinoin—Confusional state—Epirubicin—thyroid cancer	5.65e-05	0.000395	CcSEcCtD
Isotretinoin—Palpitations—Doxorubicin—thyroid cancer	5.61e-05	0.000393	CcSEcCtD
Isotretinoin—Oedema—Epirubicin—thyroid cancer	5.6e-05	0.000392	CcSEcCtD
Isotretinoin—Anaphylactic shock—Epirubicin—thyroid cancer	5.6e-05	0.000392	CcSEcCtD
Isotretinoin—Loss of consciousness—Doxorubicin—thyroid cancer	5.58e-05	0.000391	CcSEcCtD
Isotretinoin—Infection—Epirubicin—thyroid cancer	5.56e-05	0.000389	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	5.55e-05	0.000485	CbGpPWpGaD
Isotretinoin—Cough—Doxorubicin—thyroid cancer	5.54e-05	0.000388	CcSEcCtD
Isotretinoin—Shock—Epirubicin—thyroid cancer	5.51e-05	0.000386	CcSEcCtD
Isotretinoin—Convulsion—Doxorubicin—thyroid cancer	5.5e-05	0.000385	CcSEcCtD
Isotretinoin—Nervous system disorder—Epirubicin—thyroid cancer	5.49e-05	0.000384	CcSEcCtD
Isotretinoin—Thrombocytopenia—Epirubicin—thyroid cancer	5.48e-05	0.000384	CcSEcCtD
Isotretinoin—Hypertension—Doxorubicin—thyroid cancer	5.48e-05	0.000384	CcSEcCtD
Isotretinoin—Tachycardia—Epirubicin—thyroid cancer	5.46e-05	0.000383	CcSEcCtD
Isotretinoin—Skin disorder—Epirubicin—thyroid cancer	5.44e-05	0.000381	CcSEcCtD
Isotretinoin—Hyperhidrosis—Epirubicin—thyroid cancer	5.41e-05	0.000379	CcSEcCtD
Isotretinoin—Myalgia—Doxorubicin—thyroid cancer	5.4e-05	0.000378	CcSEcCtD
Isotretinoin—Arthralgia—Doxorubicin—thyroid cancer	5.4e-05	0.000378	CcSEcCtD
Isotretinoin—Chest pain—Doxorubicin—thyroid cancer	5.4e-05	0.000378	CcSEcCtD
Isotretinoin—Anxiety—Doxorubicin—thyroid cancer	5.39e-05	0.000377	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	5.37e-05	0.000376	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	5.36e-05	0.000468	CbGpPWpGaD
Isotretinoin—Discomfort—Doxorubicin—thyroid cancer	5.34e-05	0.000374	CcSEcCtD
Isotretinoin—Anorexia—Epirubicin—thyroid cancer	5.34e-05	0.000374	CcSEcCtD
Isotretinoin—Dry mouth—Doxorubicin—thyroid cancer	5.29e-05	0.00037	CcSEcCtD
Isotretinoin—Hypotension—Epirubicin—thyroid cancer	5.23e-05	0.000366	CcSEcCtD
Isotretinoin—Confusional state—Doxorubicin—thyroid cancer	5.22e-05	0.000366	CcSEcCtD
Isotretinoin—Oedema—Doxorubicin—thyroid cancer	5.18e-05	0.000363	CcSEcCtD
Isotretinoin—Anaphylactic shock—Doxorubicin—thyroid cancer	5.18e-05	0.000363	CcSEcCtD
Isotretinoin—Infection—Doxorubicin—thyroid cancer	5.15e-05	0.00036	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	5.1e-05	0.000357	CcSEcCtD
Isotretinoin—Shock—Doxorubicin—thyroid cancer	5.1e-05	0.000357	CcSEcCtD
Isotretinoin—Nervous system disorder—Doxorubicin—thyroid cancer	5.08e-05	0.000356	CcSEcCtD
Isotretinoin—Thrombocytopenia—Doxorubicin—thyroid cancer	5.07e-05	0.000355	CcSEcCtD
Isotretinoin—Insomnia—Epirubicin—thyroid cancer	5.06e-05	0.000355	CcSEcCtD
Isotretinoin—Tachycardia—Doxorubicin—thyroid cancer	5.06e-05	0.000354	CcSEcCtD
Isotretinoin—Skin disorder—Doxorubicin—thyroid cancer	5.03e-05	0.000352	CcSEcCtD
Isotretinoin—Paraesthesia—Epirubicin—thyroid cancer	5.03e-05	0.000352	CcSEcCtD
Isotretinoin—Hyperhidrosis—Doxorubicin—thyroid cancer	5.01e-05	0.000351	CcSEcCtD
Isotretinoin—Dyspnoea—Epirubicin—thyroid cancer	4.99e-05	0.00035	CcSEcCtD
Isotretinoin—Somnolence—Epirubicin—thyroid cancer	4.98e-05	0.000349	CcSEcCtD
Isotretinoin—Anorexia—Doxorubicin—thyroid cancer	4.94e-05	0.000346	CcSEcCtD
Isotretinoin—Dyspepsia—Epirubicin—thyroid cancer	4.93e-05	0.000345	CcSEcCtD
Isotretinoin—Decreased appetite—Epirubicin—thyroid cancer	4.87e-05	0.000341	CcSEcCtD
Isotretinoin—Hypotension—Doxorubicin—thyroid cancer	4.84e-05	0.000339	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Epirubicin—thyroid cancer	4.83e-05	0.000338	CcSEcCtD
Isotretinoin—Fatigue—Epirubicin—thyroid cancer	4.83e-05	0.000338	CcSEcCtD
Isotretinoin—Pain—Epirubicin—thyroid cancer	4.79e-05	0.000335	CcSEcCtD
Isotretinoin—Constipation—Epirubicin—thyroid cancer	4.79e-05	0.000335	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	4.72e-05	0.00033	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—TPR—thyroid cancer	4.71e-05	0.000411	CbGpPWpGaD
Isotretinoin—Insomnia—Doxorubicin—thyroid cancer	4.69e-05	0.000328	CcSEcCtD
Isotretinoin—Paraesthesia—Doxorubicin—thyroid cancer	4.65e-05	0.000326	CcSEcCtD
Isotretinoin—Dyspnoea—Doxorubicin—thyroid cancer	4.62e-05	0.000323	CcSEcCtD
Isotretinoin—Feeling abnormal—Epirubicin—thyroid cancer	4.61e-05	0.000323	CcSEcCtD
Isotretinoin—Somnolence—Doxorubicin—thyroid cancer	4.61e-05	0.000322	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Epirubicin—thyroid cancer	4.58e-05	0.000321	CcSEcCtD
Isotretinoin—Dyspepsia—Doxorubicin—thyroid cancer	4.56e-05	0.000319	CcSEcCtD
Isotretinoin—Decreased appetite—Doxorubicin—thyroid cancer	4.5e-05	0.000315	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	4.47e-05	0.000313	CcSEcCtD
Isotretinoin—Fatigue—Doxorubicin—thyroid cancer	4.47e-05	0.000313	CcSEcCtD
Isotretinoin—Urticaria—Epirubicin—thyroid cancer	4.45e-05	0.000311	CcSEcCtD
Isotretinoin—Constipation—Doxorubicin—thyroid cancer	4.43e-05	0.00031	CcSEcCtD
Isotretinoin—Pain—Doxorubicin—thyroid cancer	4.43e-05	0.00031	CcSEcCtD
Isotretinoin—Abdominal pain—Epirubicin—thyroid cancer	4.43e-05	0.00031	CcSEcCtD
Isotretinoin—Body temperature increased—Epirubicin—thyroid cancer	4.43e-05	0.00031	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—MEN1—thyroid cancer	4.42e-05	0.000386	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Doxorubicin—thyroid cancer	4.27e-05	0.000299	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Doxorubicin—thyroid cancer	4.24e-05	0.000297	CcSEcCtD
Isotretinoin—RARG—Gene Expression—PPARG—thyroid cancer	4.17e-05	0.000364	CbGpPWpGaD
Isotretinoin—Hypersensitivity—Epirubicin—thyroid cancer	4.13e-05	0.000289	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	4.12e-05	0.000359	CbGpPWpGaD
Isotretinoin—Urticaria—Doxorubicin—thyroid cancer	4.12e-05	0.000288	CcSEcCtD
Isotretinoin—Body temperature increased—Doxorubicin—thyroid cancer	4.1e-05	0.000287	CcSEcCtD
Isotretinoin—Abdominal pain—Doxorubicin—thyroid cancer	4.1e-05	0.000287	CcSEcCtD
Isotretinoin—Asthenia—Epirubicin—thyroid cancer	4.02e-05	0.000281	CcSEcCtD
Isotretinoin—Pruritus—Epirubicin—thyroid cancer	3.96e-05	0.000277	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—PPARG—thyroid cancer	3.88e-05	0.000339	CbGpPWpGaD
Isotretinoin—Diarrhoea—Epirubicin—thyroid cancer	3.83e-05	0.000268	CcSEcCtD
Isotretinoin—Hypersensitivity—Doxorubicin—thyroid cancer	3.82e-05	0.000267	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—PPARG—thyroid cancer	3.81e-05	0.000333	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—PPARG—thyroid cancer	3.74e-05	0.000327	CbGpPWpGaD
Isotretinoin—Asthenia—Doxorubicin—thyroid cancer	3.72e-05	0.00026	CcSEcCtD
Isotretinoin—Dizziness—Epirubicin—thyroid cancer	3.7e-05	0.000259	CcSEcCtD
Isotretinoin—Pruritus—Doxorubicin—thyroid cancer	3.67e-05	0.000257	CcSEcCtD
Isotretinoin—RXRA—Metabolism—TPR—thyroid cancer	3.66e-05	0.00032	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	3.66e-05	0.000319	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—PPARG—thyroid cancer	3.65e-05	0.000319	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PRKAR1A—thyroid cancer	3.6e-05	0.000314	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—PPARG—thyroid cancer	3.59e-05	0.000313	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—PPARG—thyroid cancer	3.59e-05	0.000313	CbGpPWpGaD
Isotretinoin—Vomiting—Epirubicin—thyroid cancer	3.56e-05	0.000249	CcSEcCtD
Isotretinoin—Diarrhoea—Doxorubicin—thyroid cancer	3.54e-05	0.000248	CcSEcCtD
Isotretinoin—Rash—Epirubicin—thyroid cancer	3.53e-05	0.000247	CcSEcCtD
Isotretinoin—Dermatitis—Epirubicin—thyroid cancer	3.53e-05	0.000247	CcSEcCtD
Isotretinoin—Headache—Epirubicin—thyroid cancer	3.51e-05	0.000246	CcSEcCtD
Isotretinoin—Dizziness—Doxorubicin—thyroid cancer	3.43e-05	0.00024	CcSEcCtD
Isotretinoin—Nausea—Epirubicin—thyroid cancer	3.33e-05	0.000233	CcSEcCtD
Isotretinoin—Vomiting—Doxorubicin—thyroid cancer	3.29e-05	0.000231	CcSEcCtD
Isotretinoin—Rash—Doxorubicin—thyroid cancer	3.27e-05	0.000229	CcSEcCtD
Isotretinoin—Dermatitis—Doxorubicin—thyroid cancer	3.26e-05	0.000228	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.26e-05	0.000285	CbGpPWpGaD
Isotretinoin—Headache—Doxorubicin—thyroid cancer	3.25e-05	0.000227	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	3.09e-05	0.00027	CbGpPWpGaD
Isotretinoin—Nausea—Doxorubicin—thyroid cancer	3.08e-05	0.000215	CcSEcCtD
Isotretinoin—RXRA—Metabolism—SLC5A5—thyroid cancer	2.74e-05	0.000239	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.57e-05	0.000224	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.24e-05	0.000195	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—NRAS—thyroid cancer	2.24e-05	0.000195	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—KRAS—thyroid cancer	1.92e-05	0.000168	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—PPARG—thyroid cancer	1.87e-05	0.000163	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—AKT1—thyroid cancer	1.65e-05	0.000144	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—HRAS—thyroid cancer	1.64e-05	0.000143	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—AKT1—thyroid cancer	1.51e-05	0.000132	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—AKT1—thyroid cancer	1.48e-05	0.000129	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PPARG—thyroid cancer	1.45e-05	0.000127	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—AKT1—thyroid cancer	1.44e-05	0.000126	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—AKT1—thyroid cancer	1.42e-05	0.000124	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—AKT1—thyroid cancer	1.42e-05	0.000124	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTGS2—thyroid cancer	1.14e-05	9.98e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTEN—thyroid cancer	9.97e-06	8.7e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—AKT1—thyroid cancer	7.39e-06	6.45e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—AKT1—thyroid cancer	5.75e-06	5.02e-05	CbGpPWpGaD
